Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

France Piétri-Rouxel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Science Translational Medicine|November 8, 2019
An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouseMassiré Traoré, Christel Gentil, Chiara Benedetto, et al.
Human Molecular Genetics|July 6, 2016
Antisense pre-treatment increases gene therapy efficacy in dystrophic musclesCécile Peccate, Amédée Mollard, Maëva Le Hir, et al.
The Journal of Cell Biology|May 7, 2014
Actin scaffolding by clathrin heavy chain is required for skeletal muscle sarcomere organizationStéphane Vassilopoulos, Christel Gentil, Jeanne Lainé, et al.
Human Gene Therapy|June 29, 2013
Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathyJohn Rendu, Julie Brocard, Eric Denarier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2014
Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathyKarima Relizani, Etienne Mouisel, Benoit Giannesini, et al.
EMBO Molecular Medicine|March 15, 2017
Delivery is key: lessons learnt from developing splice-switching antisense therapiesCaroline Godfrey, Lourdes R Desviat, Bård Smedsrød, et al.
The Journal of Biological Chemistry|March 15, 2018
Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletionsOlivier Delalande, Anne-Elisabeth Molza, Raphael Dos Santos Morais, et al.
JCI Insight|August 2, 2022
NR1D1 controls skeletal muscle calcium homeostasis through myoregulin repressionAlexis Boulinguiez, Christian Duhem, Alicia Mayeuf-Louchart, et al.
EMBO Molecular Medicine|March 17, 2022
CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotypeAntoine de Zélicourt, Abdallah Fayssoil, Mbarka Dakouane-Giudicelli, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Science Translational Medicine|November 8, 2019
An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouseMassiré Traoré, Christel Gentil, Chiara Benedetto, et al.
Human Molecular Genetics|July 6, 2016
Antisense pre-treatment increases gene therapy efficacy in dystrophic musclesCécile Peccate, Amédée Mollard, Maëva Le Hir, et al.
The Journal of Cell Biology|May 7, 2014
Actin scaffolding by clathrin heavy chain is required for skeletal muscle sarcomere organizationStéphane Vassilopoulos, Christel Gentil, Jeanne Lainé, et al.
Human Gene Therapy|June 29, 2013
Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathyJohn Rendu, Julie Brocard, Eric Denarier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2014
Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathyKarima Relizani, Etienne Mouisel, Benoit Giannesini, et al.
EMBO Molecular Medicine|March 15, 2017
Delivery is key: lessons learnt from developing splice-switching antisense therapiesCaroline Godfrey, Lourdes R Desviat, Bård Smedsrød, et al.
The Journal of Biological Chemistry|March 15, 2018
Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletionsOlivier Delalande, Anne-Elisabeth Molza, Raphael Dos Santos Morais, et al.
JCI Insight|August 2, 2022
NR1D1 controls skeletal muscle calcium homeostasis through myoregulin repressionAlexis Boulinguiez, Christian Duhem, Alicia Mayeuf-Louchart, et al.
EMBO Molecular Medicine|March 17, 2022
CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotypeAntoine de Zélicourt, Abdallah Fayssoil, Mbarka Dakouane-Giudicelli, et al.
Pageof 2